Levels of vitellogenin (VG) and vitellogenesis-inhibiting hormone (VIH) in the whiteleg shrimp, Litopenaeus vannamei, were measured by time-resolved fluoroimmunoassay in relation to the molting cycle and ovarian maturation induced by eyestalk ablation. During the molt cycle, VG mRNA expression levels and VG concentrations showed similar patterns of fluctuation. VG levels increased significantly at early intermolt (stage C0) in adults, but not in subadults. Unilateral and bilateral eyestalk ablation increased VG levels in adults, whereas only bilateral eyestalk ablation affected subadults. VIH levels showed contrasting patterns between adults and subadults. In adults, levels were high in late postmolt adults (stage B) and then low thereafter, whereas they increased from postmolt (stage A) to intermolt (stage C0) in subadults and remained high. Unilateral eyestalk ablation increased VIH levels 10 days following ablation in adults, after which levels decreased at 20 days. VIH levels decreased from 10 to 20 days after bilateral ablation. Both unilateral and bilateral ablation led to increased VIH levels in subadults. Eyestalk ablation induced ovarian maturation, but did not reduce VIH concentrations in the hemolymph. This phenomenon was perhaps due to other crustacean hyperglycemic hormone peptides having cross-reactivity with VIH antibodies. This is the first report to quantify concentrations of VG and VIH together in L. vannamei hemolymph, and to examine their relative dynamics.
INTRODUCTION
The process of vitellogenesis is an important component of female crustacean reproduction. Vitellogenin (VG), the precursor of the major egg yolk protein, vitellin (VT), is synthesized principally at the hepatopancreas and ovary in decapods, secreted into the hemolymph, and then accumulated in the developing oocytes. Levels of VG in hemolymph or of VG mRNA expression at the VG synthetic sites may potentially be employed as markers of ovarian maturation, as VG levels fluctuate with the reproductive cycle [1] [2] [3] . Reproduction is also closely related to molting and body size. For example, ovarian maturation in diecdysic species such as Macrobrachium rosenbergii occurs concomitantly with the progression of the molt cycle [1, 4] , whereas in other species it occurs over more than one molting cycle according to season [1, 2] .
Vitellogenesis and molting are hormonally regulated. In decapods, vitellogenesis-inhibiting hormone (VIH) negatively regulates reproduction. VIH is a neuropeptide belonging to the crustacean hyperglycemic hormone (CHH) family. CHHfamily peptides are synthesized and secreted as neuropeptides from the X-organ/sinus gland complex in the eyestalks. The CHH family is known to include CHH, VIH, molt-inhibiting hormone (MIH), and mandibular organ-inhibiting hormone (MOIH). CHH regulates carbohydrate metabolism, whereas MIH inhibits ecdysteroid synthesis at the Y-organs. MOIH suppresses methyl farnesoate synthesis at the mandibular organ. CHH-family peptides can be classified into two subtypes depending on the presence of a glycine residue at position 12 in the mature peptide: CHH is a type I peptide (absence), whereas VIH, MIH, and MOIH are type II peptides (presence) [3, [5] [6] [7] . In addition, it is possible that CHH-family peptides show crossover roles; for example, VIH peptide may also have CHH activity, and vice versa.
The whiteleg shrimp, Litopenaeus vannamei, is at present one of the most significant species targeted in commercial aquaculture, and is also often employed in reproductive studies [3, [8] [9] [10] [11] [12] . We have previously isolated six type I CHH-family peptides that can significantly inhibit the transcription of VG mRNA from the sinus gland of L. vannamei, with L. vannamei sinus gland peptide-G (Liv-SGP-G) being the predominant species present [11] . In order to further clarify the role of VIH in reproduction, we consider it important to assess ovarian maturation in relation to VIH levels in vivo and to compare these levels with those of VG in the hemolymph. Because eyestalk ablation removes the source of the suppressive hormone and thus accelerates the molting cycle and vitellogenesis, eyestalk ablation is commonly used to advance ovarian maturation. Although it is a frequently employed method, it often leads to decreased egg quality and high larval mortality [13] . In order to develop alternative methods to eyestalk ablation, it is necessary to obtain basic information on how VG and VIH fluctuate in accordance with the molt cycle, and to better understand the effects of eyestalk ablation on hormonal patterns. Hence, we examined VG and VIH levels as a function of the molt cycle during maturation induced by eyestalk ablation. This is the first study to quantify the concentrations of VG and VIH together in L. vannamei hemolymph, and to examine their dynamics in relation to molting and eyestalk ablation.
MATERIALS AND METHODS

Animals
Whiteleg shrimp subadults (body weight, 15.4 6 3.3 g, mean 6 SD) were purchased from International Mariculture Technology, and adults (37.1 6 6.8 g) from Saikaew Hatchery. In general, adults are defined as ranging from 25 to 50 g in body weight, whereas subadults are defined as ranging from 10 to 20 g in body weight. All shrimp were held for at least 2 wk in recirculated natural seawater at 288C and fed on a commercial diet at a rate of 1.5% of body weight per day (Goldprawn; Higashimaru Co.) until use. Female shrimps were employed, and one or both eyestalks were removed by cauterization with redhot tweezers; such individuals were then sampled at 0, 10, or 20 days thereafter. Intact females served as controls and were sampled according to the same time schedule.
For purposes of quantifying VG and VIH as a function of molt stage, five to seven females were sampled at each molt stage for both adults and subadults. Molt stage was examined by excising the endopodite of the fifth pleopod, flattening it in saline between a slide glass and cover slip, and observing it under a light microscope. Molt stage was defined following the methods of Chan et al. [14] as follows: stage A, setal lumen filled with translucent fiberlike matrix; stage B, matrix retracting in setal lumen; stage C0, setal lumen clear and formatted internal cones complete; stage C1, just before apolysis; stage D0, separation of endocuticle from epidermis; stage D2, new setae have formed setal spines.
Hemolymph was taken by syringe (1 ml) from the body cavity via the abdominal sternite, and was quick frozen at À808C without the addition of anticoagulants. Prior to use in measurement for VG and VIH, hemolymph samples were removed from storage at À808C and defrosted. Next, they were agitated with a pipette tip and centrifuged at 48C, 20 000 3 g, for 5 min in order to obtain supernatant. The hepatopancreas and ovary were dissected out, weighed, frozen immediately in liquid nitrogen, and stored at À808C until use. The gonadosomatic index (GSI) was calculated as gonad weight (g)/body weight (g) 3 100 and expressed as a percentage. Care and handling of the experimental animals were conducted in accordance with institute regulations and Japanese law [15] .
Purification of VT
In order to prepare purified VT for use as a standard in the measurement of VG, an ovary from a mature female was homogenized on ice in Tris-buffered saline (20 mM Tris-HCl, pH 8, 0.01% EDTA, 150 mM NaCl), and centrifuged at 48C, 10 000 3 g, for 30 min. The supernatant was precipitated by centrifuging with the same volume of saturated ammonium sulfate. The precipitate was suspended again in Tris buffer (20 mM Tris-HCl, pH 8, 0.01% EDTA) and dialyzed, and then applied to a TSKgel DEAE-5PW column (Tosoh) equilibrated with Tris buffer. The column was washed with 10 ml of Tris buffer and then the protein was eluted by a linear NaCl gradient (0-0.5 M) with a flow rate of 1 ml min À1 . Each fraction was subjected to SDS-PAGE and Western blot analysis as described below.
Western Blot Analysis and Amino Acid Sequencing for VG
Cross-immunoreaction between VG of L. vannamei and VT antiserum of Penaeus japonicus (anti-PjVn) [16] was tested by Western blot analysis (antiPjVn antiserum was generously provided by Professor Emeritus Katsumi Aida, the University of Tokyo). Increased VG levels were induced by bilateral eyestalk ablation of female adults. Hemolymph samples taken from eyestalkablated adult females and intact subadult females were diluted (1:10) with Laemmli sample buffer (Bio-Rad). An ovary sample collected from an adult specimen 10 days after ablation was homogenized in sample buffer, and the supernatant obtained by centrifuging was used as ovarian extract. The purified VT was also diluted with sample buffer (ovary [g]: sample buffer [ml] ¼ 1:100), and the equivalent volume containing 100 ng of VT was applied per lane. As a positive control, hemolymph and ovary from a mature female P. japonicus (36.6 g in body weight, 5.66% in GSI) were obtained using the same methods. Polypeptides were separated by SDS-PAGE on a 5%-20% gel and transferred to a PVDF membrane (Immunobilon; Millipore) on a semidry transfer apparatus (Trans-blotSD, Bio-Rad). The membrane was washed in washing buffer (10 mM Tris-HCl, pH 8, 100 mM NaCl, 0.05% Tween 20), blocked with blocking buffer (2% bovine serum albumin [BSA] in washing buffer), and then reacted with anti-PjVn serum (diluted 1:5000 in blocking buffer). After washing, the membrane was reacted with secondary antibody (goat anti-rabbit IgG-AP; CosmoBio) and developed in NBT/BCIP stock solution (Roche).
For amino acid sequencing, purified VT was separated by SDS-PAGE and transferred to a PVDF membrane. The membrane was stained lightly with Ponceau S, destained in distilled water, and dried. Polypeptide bands were cut out and analyzed on an Applied Biosystems model 491cLC protein sequencer in the pulsed-liquid mode.
Recombinant VIH and Polyclonal Antibody
Recombinant VIH of L. vannamei (Liv-rVIH) was obtained as previously reported for Liv-rSGP-G [17] . Briefly, DNA for Liv-SGP-G was amplified by PCR and the first Ala residue in natural Liv-SGP-G was substituted with a Gly residue (Liv-SGP-G-Gly; the precursor form of Liv-SGP-G). This DNA fragment (Liv-SGP-G-Gly) was inserted into a pET-44a (þ) plasmid (Novagen Inc.) after digestion with SamI and EcoRI. Recombinant peptides were expressed in Escherichia coli strain BL21 (DE3) STAR (Invitrogen) and applied to a Ni Sepharose 6 Fast Flow column (GE Healthcare), and then purified by reversed-phase HPLC on a PEGASIL ODS SP300 column (Senshu Scientific Tokyo). After mass spectral analysis and N-terminal amino acid sequencing, purified Liv-rVIH (Liv-rSGP-G) was used for the measurement system.
Polyclonal antibodies against Liv-rVIH (anti-Liv-rVIH) were prepared using a custom antibody production service (Takara Bio Inc.). Japanese white rabbits were immunized by a subcutaneous injection that was administered four times at about 2-wk intervals. The antiserum was purified using a Protein A column; purified anti-Liv-rVIH-IgG was obtained in solution at a concentration of 13.2 mg ml À1 and stored at À808C until used. The immunoreactivity of anti-Liv-rVIH was tested with purified Liv-rVIH and extracts of sinus gland by Western blot analysis. Sinus glands were dissected from immature female subadults and homogenized in sample buffer, and the supernatant obtained by centrifuging (48C, 10 000 3 g, for 10 min) was used as sinus gland extract. Purified Liv-rVIH and extracts of sinus gland were applied to a 15% SDS-PAGE gel, and subsequent procedures were the same as Western blot analysis for VG described above, except regarding primary antibody. In this case, diluted anti-Liv-rVIH (528 ng ml
À1
) was used as the primary antibody.
Time-Resolved Fluoroimmunoassay for VIH
VIH in hemolymph was measured by time-resolved fluoroimmunoassay (TR-FIA) as follows. First, 200 ll of hemolymph for a single shrimp was mixed with the same volume of acetonitrile and centrifuged at 20 000 3 g, 48C, for 20 min. The supernatant was concentrated by centrifugation under reduced pressure to evaporate the acetonitrile. The concentrate was mixed with 100 ll of 30% trichloroacetic acid and centrifuged at 20 000 3 g, 48C, for 20 min. The supernatant was then freeze dried and stored at À208C until use.
For quantification of VIH, the wells of 96-well plates (DELFIA Yellow; Perkin Elmer) were coated with standards or pretreated hemolymph samples. Liv-rVIH was used as a standard and diluted with 0.1 M carbonate buffer (CB) (pH 9.6) from 40.00 to 0.08 ng ml À1 ; each well received 0.2 ml. Pretreated hemolymph samples were dissolved in 0.4 ml CB and added in duplicate to wells (0.2 ml per well). The plate was incubated at 48C overnight. After coating, the wells were washed five times for 3 min at a time with 0.3 ml of washing buffer (50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 0.05% Tween 20) in an ImmunoWash 1575 Microplate Washer (Bio-Rad), and then blocked with 0.3 ml of assay buffer (Perkin Elmer) at 248C for 2 h. After five washes, primary antibody (2 lg ml À1 ), e.g., polyclonal antibody raised against LivrVIH diluted in assay buffer, was added to the plate (0.2 ml per well), and the plate was incubated for 2 h at 248C. After five washes, secondary antibody (DELFIA Eu-N1-labeled anti-rabbit antibody; Perkin Elmer) was diluted (1:2000) in assay buffer and then added to the plate (0.2 ml per well), and the plate was incubated for 2 h at 248C. After five washes, 0.2 ml of enhancement solution (Perkin Elmer) was added to the plate, the wells were incubated for 40 min at 248C, and then europium (Eu) fluorescence was measured by a timeresolved fluorometer (Wallac 1420 ARVOsx-d; Perkin Elmer). VIH concentrations were calculated using MultiCalc software (Perkin Elmer).
The verification of the above measurement system for VIH was accomplished as follows by testing varying conditions using 96-well plates. The standard curve employed serially diluted Liv-rVIH ranging from 100 ng to 7.81 pg per well; the blocking buffer was tested with 0%, 0.5%, and 1% BSA added to assay buffer; the primary antibody was tested using anti-Liv-rVIH at contents of 50, 100, 150, 200, and 400 ng per well. The secondary antibody (1.326 mg ml À1 ; 8.288 lM) was tested at dilution ratios of 1:1000, 1:1250, 1:2000, and 1:5000. The optimal conditions for obtaining an appropriate standard curve were thus determined (and selected for use as above).
To examine parallelism of the standard curve with test samples, sinus glands were extracted using several different processes as follows: a sinus gland from one eyestalk each was homogenized respectively in 0.1 ml of one of three solutions: 30% methanol, 30% methanol and 0.9% NaCl, or 50% acetonitrile. Supernatant was obtained by centrifuging at 15 000 3 g, 48C, for 10 min, and the pellet was washed with an additional 0.1 ml of extraction solution. The KANG ET AL. resultant supernatant after centrifugation as above was combined with the previous, and the extracts were concentrated by centrifugation under reduced pressure and freeze dried. In addition, 30% trichloroacetic acid was added to the supernatant to concentrated homogenized sinus gland in the case of 50% acetonitrile, after which the supernatant was centrifuged at 20 000 3 g, 48C, for 20 min and then freeze dried. Sinus gland extracts were serially diluted to encompass the range of 1:100 to 1:12 800, and parallelism with the standard curve for each type of extraction was examined.
Recoveries were tested at three points (0.4, 0.6, and 0.8 ng of Liv-rVIH per well) in duplicate, using 0.1 M CB (pH 9.6). Test CB (0.2 ml) was added with the above quantities of Liv-rVIH, or with no addition of Liv-rVIH, and measured for VIH. Recovery was calculated by subtracting the measured quantity of VIH in CB samples from that measured in CB samples added with rVIH, divided by the corresponding actual quantity of Liv-rVIH multiplied by 100.
TR-FIA for VG
For the quantification of VG, untreated hemolymph samples were diluted 1:2000 with CB. Purified VT was used as a standard, diluted with 0.1 M CB (pH 9.6) containing male hemolymph (1:2000 dilution) from 20.00 to 0.04 ng per well. The wells were coated with 0.1 ml of diluted hemolymph samples or standards, and then blocked with 0.3 ml of 1% BSA in assay buffer. Diluted anti-PjVn (1:10 000 in assay buffer), used as the primary antibody, was added to wells (0.1 ml per well). Next, 0.1 ml of diluted secondary antibody (DELFIA Eu-N1-labeled anti-rabbit antibody) and enhancement solution (Perkin Elmer) was added to wells. Subsequent procedures for measuring Eu fluorescence and calculation of values were the same as for the VIH system described above.
In order to verify the above measurement system for VG, varying conditions were tested as follows. The range for the standard curve was determined using serially diluted purified VT starting from 200 ng to 0.04 ng per well; the blocking buffer was tested with 0.5%, 1%, and 2% of BSA added to the assay buffer; the primary antibody consisted of anti-PjVn diluted to 1:3000, 1:5000, 1:7000, 1:10 000, 1:14 000, and 1:20 000. The secondary antibody (1.326 mg ml À1 ; 8.288 lM) was tested at a dilution ratio of 1:1000, 1:1250, 1:2000, and 1:5000. To determine the appropriate dilution ratios of hemolymph, parallelism was tested between the standard curve and test samples with and without male hemolymph (e.g. VG-free hemolymph), which were diluted to 1:1000, 1:2000, 1:4000, 1:5000, 1:6000, 1:10 000, 1:20 000, and 1:40 000. Optimal conditions for obtaining an appropriate standard curve were thus determined (and selected for use as above). To equalize the conditions between standards and samples, purified VT was diluted in CB containing male hemolymph at the same dilution ratio as samples, and used in the standard curve.
Recoveries were tested at three points (2, 4, and 8 ng of purified VT per well) in duplicate, using male hemolymph diluted with 0.1 M CB (pH 9.6). Diluted (1:2000) male hemolymph (0.1 ml) was added with the above quantities of purified VT, or with no addition of purified VT, and measured for VG. Recovery was calculated by subtracting the measured quantity of VG in diluted male hemolymph samples from that measured in male hemolymph samples added with purified VT, divided by the corresponding actual quantity of purified VT multiplied by 100.
Quantitative Real-Time RT-PCR of VG mRNA Quantitative real-time RT-PCR was performed using the Platinum Quantitative RT-PCR Thermoscript One-Step System (Invitrogen) according to the protocol of the manufacturer. Total RNAs were extracted from ovary and hepatopancreas with an RNeasy Mini Kit (Qiagen) and used as templates.
VG and beta-actin (ACTB) mRNAs were amplified with the primers and probes reported in a previous study [17] . Levels of mRNA were determined by real-time monitoring of the fluorescence signal generated during PCR amplification on a 7500 Fast Real-Time PCR system (Applied Biosystems). For VG mRNA, the amplification conditions were an initial 608C for 30 min and 958C for 5 min, followed by 40 cycles of 958C for 15 sec and 648C for 1 min. For ACTB mRNA they were an initial 608C for 15 min and 958C for 5 min, followed by 40 cycles of 958C for 15 sec and 628C for 1 min.
To plot standard curves for VG and ACTB mRNA, 1 lg of total RNA extracted from mature ovary was serially diluted (assigned an arbitrary value of 100 000) to 10 pg. The standard curves were linear over six orders of magnitude, with correlations of .0.98 between threshold cycles and relative mRNA levels (data not shown). All samples were analyzed in duplicate, and the expression of VG mRNA was normalized to that of ACTB mRNA.
Statistics
All results are expressed as the mean 6 SEM. Significance was assessed by one-way ANOVA with the Duncan method for differences among molt stage groups, and with the Holm-Sidak method for comparison of controls with ablation groups. All analyses were done using SigmaPlot 11 software, and were considered to be statistically significant at P , 0.05.
Histology
In order to examine oocyte development as a function of molt stage as well as eyestalk ablation, two or three individuals were selected randomly from representative molt stages (A, B, C0, C1, D0, D2) and from among eyestalkablated individuals at 0, 10, or 20 [3, 12] .
RESULTS
Purification and Identification of VT
VG was induced by bilateral eyestalk ablation and was demonstrated to cross-react with anti-PjVn (Fig. 1A) . AntiPjVn antiserum reacted with several polypeptides in the hemolymph and ovarian extracts of L. vannamei, as well as the positive control consisting of P. japonicus hemolymph and ovary. In the hemolymph of ablated adult L. vannamei, two polypeptides were detected, a strong 72-kDa band and a faint 205-kDa band, but such bands were not observed in subadults. Moreover, anti-PjVn reacted strongly with 72-and 45-kDa bands, and faintly with 186-and 103-kDa bands in ovarian extracts, as well as with a 72-kDa band from purified VT in L. vannamei (Fig. 1A) . These results suggest that the 72-kDa polypeptide is the actual VT that is accumulated in the ovary. In this way, immunoreactivity between anti-PjVn and VG of L. vannamei was well revealed on Western blot analysis, and therefore we considered it valid to utilize anti-PjVn as the primary antibody in the measurement of VG.
The application of ovarian extract to ion chromatography using a TSKgel DEAE-5PW column yielded two main peaks; the polypeptides obtained from the peaks each had a molecular mass of 72 kDa as determined by Western blot analysis. The single 72-kDa polypeptide in the first peak had an N-terminal sequence of APWGADVPRC, which corresponded to the previously deduced sequence of VG at positions 19-28 reported by Raviv et al. [10] . The two polypeptides in the second peak had N-terminal sequences of DAGGEXDA (matching that of hemocyanin) and DVQQEXDVLY. These sequences had no homology with VG; thus, we used the fraction of the first peak as the valid purified VT to serve as the standard for measuring VG.
Liv-rVIH and Polyclonal Antibody
Immunoreaction between VIH and anti-Liv-rVIH was confirmed by Western blot analysis (Fig. 1B) . Anti-Liv-rVIH reacted strongly with a 7-kDa polypeptide in extracts of sinus gland, and also with purified Liv-rVIH. This result is the first categorization of the immunoreaction of VIH in L. vannamei, and is in agreement with a previous report that has indicated the molecular mass of VIH to be 8338 Da by mass spectral analysis [11] . VIH (Liv-SGP-G) is the most abundant CHHfamily peptide in the sinus gland, with an expected amount of approximately 450 ng in a single sinus gland [11] . We also compared on Western blot analysis the reaction of anti-Liv-
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rVIH with native VIH totally contained in one sinus gland (using two separate individuals) with the reaction of anti-LivrVIH with 100 ng of purified Liv-rVIH (Fig. 1B) . This indicates that purified Liv-rVIH reacts sufficiently and in the same manner with anti-Liv-rVIH as does native VIH. Therefore, Liv-rVIH and anti-Liv-rVIH were used as the standard and primary antibody respectively in the measurement system for VIH.
Measurement of VG and VIH
VG was measured by TR-FIA. The appropriate level of dilution for hemolymph samples was determined using purified VT and male hemolymph. In addition, standard curves using purified VT and those using purified VT added with male hemolymph were parallel over dilutions of hemolymph starting from a level of 1:2000. However, at extremely high dilutions, it was not possible to measure VG in the samples; therefore, a 2000-fold level of dilution was chosen for the actual assay system. Purified VT added with male hemolymph at the same dilution rate was used as the standard curve to standardize conditions for samples (data not shown). The intra-assay coefficients of variation were 4.5%-5.8% and the interassay coefficients of variation were 1.42%-5.02%; recoveries ranged from 89.5% to 108.6% (three concentrations, four replications) ( Table 1) .
VIH was also measured by TR-FIA. Purified Liv-rVIH was used as a standard, and its polyclonal antibody as the primary antibody. Serial dilutions of sinus gland extract were well paralleled with the standard curve in all treatments. The intraassay coefficients of variation were 3.1%-6.6% and the interassay coefficients of variation were 3.23%-14.08%; recoveries ranged from 91.7% to 101.6% (Table 1) .
Quantification of VG in Hemolymph During the Molt Cycle
In adults, VG levels were high in stage C0 (24.98 6 11.56 lg ml À1 ), and then decreased significantly (2.26 6 0.50 lg ml À1 in stage D2 and 2.86 6 0.53 lg ml À1 in stage A; Fig.  2A ). Changes in GSI were synchronized with those of VG.
In subadults, VG levels did not change significantly and remained low (ranging from 0.85 6 0.10 lg ml À1 in stage D0 to 1.4 6 0.69 lg ml À1 in stage D2; Fig. 3A ). GSI also remained low and did not change significantly. VG levels were lower in subadults than in adults.
VG mRNA Expression Levels During the Molt Cycle
In adults, VG mRNA expression in the ovary was highest at molt stage C0, but differences were not significant because of high variance among the examined samples (Fig. 2B ). Nevertheless, levels followed the same pattern as VG in the hemolymph and GSI.
In subadults, VG mRNA expression was low at all stages, although it showed a peak at stage B (Fig. 3B ). Differences were not significant, as was the case with VG levels in the hemolymph.
VG mRNA expression in the hepatopancreas was weak or not detectable in adults and subadults (Fig. 4, A and B ). There were no statistically significant differences in the variation of ACTB expression among molt stages (data not shown). These results ensure that ACTB can be confidently utilized as the housekeeping gene, and that its expression is not influenced by molt stage when calculating VG expression.
Quantification of VIH in Hemolymph Within Molt Cycles
In adults, VIH levels increased significantly from stage A (6.13 6 1.64 ng ml À1 ) to stage B (11.18 6 2.71 ng ml À1 ), and then decreased significantly at stage C0 (2.84 6 0.86 ng ml À1 ), remaining low throughout the remainder of the molt cycle (Fig.  2C) .
In subadults, VIH levels increased significantly from stage A (2.14 6 0.44 ng ml À1 ) to stage C0 (4.81 6 0.72 ng ml À1 ) and remained high thereafter (Fig. 3C) . Levels showed similar patterns of change in adults and subadults from stages C0 to D2, but tended to be higher in adults at stages A and B.
Effects of Eyestalk Ablation on the Dynamics of VG, VIH, and VG mRNA Levels
At 10 days after ablation in adults, although there was no significant change in GSI (Fig. 5A) , VG levels increased in both groups, significantly so in the bilateral group (Fig. 5B) . At 20 days, they decreased in both groups, to the control level in the unilateral group. The expression of VG mRNA in the ovary paralleled the levels of VG (Fig. 5C) .
At 10 and 20 days after ablation in subadults, GSI and VG levels remained unaltered in the unilateral group (Fig. 6, A and  B) . On the other hand, levels increased significantly in the bilateral group. The expression of VG mRNA again paralleled the levels of VG (Fig. 6C ). There was no significant increase in the unilateral group. Expression was significantly increased in the bilateral group, although it showed a slight decrease at 20 days, as in adults.
In the hepatopancreas, VG mRNA expression was negligible in ablated adults and subadults, and did not increase even in bilaterally ablated females (Fig. 4, C and D ). There were no statistically significant differences in the variation in ACTB expression of raw data among the ablated groups (data not shown). These results ensure that ACTB can be confidently utilized as the housekeeping gene, and that its expression is not influenced by eyestalk ablation when calculating VG expression.
At 10 days after ablation in adults, VIH levels were significantly increased in the unilateral group, but at 20 days had returned to control levels (Fig. 5D ). There was no significant change in the bilateral group, although levels declined at 20 days.
At 10 days after ablation in subadults, VIH levels were significantly increased in both groups (Fig. 6D) . Levels remained high at 20 days in the unilateral group and increased further in the bilateral group.
Oocyte Development
Ovarian developmental stages of adults throughout the molt cycle (from stage A to D2) were mainly previtellogenic, in that oocytes contained mostly oogonia and previtellogenic oocytes (Fig. 7A) . However, a few early-stage endogenous vitellogenic oocytes were also observed in such ovaries (Fig. 7A) . In molt stage C0, ovaries in the endogenous vitellogenic stage were also observed in two adults having a GSI of around 1.5% (Fig.  7B ). There were no ovaries with exogenous vitellogenic oocytes in intact adults. In subadults, ovaries had oocytes that consisted completely of oogonia and previtellogenic oocytes (Fig. 7, C and D) . Endogenous vitellogenic oocytes were not observed in ovaries of intact subadults throughout the molt cycle.
In unilaterally ablated adults, ovaries presented mainly previtellogenic and endogenous vitellogenic oocytes (Fig. 7 , E and F) without significant changes in GSI (Fig. 5A) . Ten days 
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after ablation, however, mature and regressing atretic oocytes were also observed in these groups (Fig. 7E) . In the bilaterally ablated group, although GSI was not significantly changed (Fig. 5A) , exogenous vitellogenic oocytes were observed in adults (Fig. 7, G and H) . The ovaries of unilaterally ablated subadults remained at the previtellogenic stage (Fig. 7I ) without significant changes in GSI (Fig. 6A) , but endogenous and exogenous vitellogenic stage oocytes were observed 20 days following ablation (Fig. 7, J and K) . Subadult ovaries developed significantly following bilateral eyestalk ablation (Fig. 6A ) at 10 and 20 days, but still exhibited previtellogenic oocytes stages on day 10 (Fig. 7L) . Exogenous vitellogenic and regressing atretic oocytes were observed on day 20 (Fig. 7, M  and N) .
DISCUSSION
In decapod crustaceans, VG is generally cleaved firstly at the R-X-K/R-R consensus cleavage site closer to the N terminus, and then secreted into the hemolymph from the hepatopancreas. The second cleavage occurs in the C-terminal region of the VG molecule in the hemolymph or in the ovary after uptake. Therefore, two or more VG subunits are always present in the hemolymph [3] . In this study, two bands (72 and 205 kDa) were obtained from the hemolymph, and four bands (186, 103, 72, and 45 kDa) were obtained from ovarian extracts as observed by Western blot analysis using anti-PjVn (Fig.  1A) . The amino acid sequence observed for the 72-kDa subunit corresponds to that of VG after the release of its signal peptide; in this study, this subunit cross-reacted dominantly with antiPjVn, because anti-PjVn was raised against the 91 kDa of polypeptide band that is predicted by the cleavage of VG at the R-X-K/R-R consensus site [16] . This N-terminal subunit resulting from primary cleavage described above is common to L. vannamei and P. japonicus, and is reported to harbor 84% identity in terms of amino acid sequence [10] . Although the 205-kDa polypeptide in the hemolymph has not been positively identified in L. vannamei to date, it is also perhaps a VG subunit, as similar subunit patterns for VG in L. vannamei have been observed [10] . The observance of several cross-reacting bands in extracts of ovary could be a result of the processing of mature VG, and may be caused by the presence of degenerate cleavage sites near the C-terminal position. In order to fully elucidate the mechanisms of VG processing in L. vannamei, immunoblotting patterns using antibodies generated respectively against the four currently known subunits (186, 103, 72, and 45 kDa) should be examined.
Concentrations of VG and the expression of VG mRNA in ovary were higher in stage C0 intact adult females, indicating the possibility that natural maturation occurs during intermolt. As well, the results were in agreement with the histological observation of the ovaries; endogenous vitellogenic oocytes were present at molt stage C0 for adults among all intact samples. During the molt cycle, levels of VG and VIH in hemolymph fluctuated in adults, although VIH levels did not clearly correspond to VG mRNA expression at all stages. VG levels were lower in subadults than in adults, but VIH levels were similar between developmental stages. Thus, VIH levels in the hemolymph corresponded to VG levels, and VIH could therefore be considered to inhibit vitellogenesis in adults and subadults. This is the first specific report on the quantification of VIH in the hemolymph, although CHH-family peptides have been measured in several other crustacean species. In addition, levels of gonad-inhibiting hormone (another term for VIH) were qualitatively examined in the hemolymph of Homarus americanus. Arbitrary levels were lower during vitellogenesis than during the immature, previtellogenesis, and mature stages [18] . In the crab Carcinus maenas, CHH levels in the hemolymph increased from very low during intermolt (10-50 fmol ml À1 ) to high during late premolt (250 fmol ml À1 ), and to very high during ecdysis (1500-2000 fmol ml À1 ) [19] roles, not only in the regulation of carbohydrate metabolism, but also in lipid mobilization, in the control of molting, in ionoosmoregulation, and in reproduction [18] [19] [20] [21] .
Eyestalk ablation (unilateral and bilateral) increased VG levels to that seen in adults with high maturation capability. Arcos et al. [8] reported that unilateral eyestalk ablation in L. vannamei females induced the appearance of late vitellogenic and cortical stage oocytes, and increased VG levels in the hemolymph up to 85.4 6 23.2 lg ml À1 . We expected to observe the same degree of maturity of the ovary in this study because VG levels measured were higher than those reported above (Fig. 5B) . Although mature oocytes appeared, ovaries consisted almost completely of previtellogenic and endogenous vitellogenic oocytes in unilaterally ablated adults. Bilateral eyestalk ablation in subadults induced similar VG levels in the hemolymph and increased VG mRNA expression as in adults, but unilateral ablation did not, perhaps because of the high VIH levels observed in subadults as in adults, or because subadults are more sensitive to VIH than are adults. In histological observation of the above individuals, regressing atretic oocytes appeared in those eyestalk-ablated adults and subadults that had significantly higher VIH levels. In eyestalk-ablated adults, peak VIH levels in hemolymph were observed 10 days after unilateral ablation. Such samples exhibited regressing atretic oocytes. However, 20 days following ablation, the ovary returned to conditions of immaturity as observed with control samples. This suggests that a surge of VIH levels could lead to the regression of ovarian maturation, and thus these results have revealed the existence of a relationship between VIH levels and the regression of developing ovaries. In addition, in this study, VG mRNA expression in the hepatopancreas was negligible in all individuals, even in eyestalk-ablated groups. This suggests that VIH levels may have more effect on the hepatopancreas than on the ovary.
CHH-family peptides are synthesized mainly at the Xorgan/sinus gland complex, but are considered to be produced at other tissues in several species of crab and shrimp [19, [22] [23] [24] . This phenomenon is responsible for the detection of CHH in the hemolymph of bilaterally ablated species, including C. maenas, Fenneropenaeus indicus, and H. americanus, although levels decreased with time [25] [26] [27] . Here, eyestalk ablation induced ovarian maturation, yet VIH levels were not reduced significantly, even in the bilaterally ablated group; in fact, they were increased greatly irrespective of the occurrence of ovarian maturation in subadults (Fig. 6D) . Although VIH levels did not decrease following ablation as expected, we believe that ablation would affect CHH levels by causing stress to the animal and be detectable because of cross-immunoreaction. We did not test cross-immunoreaction with antibodies to other CHH-family peptides in L. vannamei, but the possibility has been revealed in other species, for example the cross-immunoreaction of sinus gland peptides with CHH antibodies in M. rosenbergii [28] . Moreover, anti-H. americanus VIH serum cross-reacted with CHH and MIH of Jasus lalandii, and antiserum to other CHH-family peptides reacted with HPLC fractions from the sinus gland of J. lalandii [29] . In addition, in preparatory tests, positive immunoreaction was obtained in several peak fractions upon the separation by HPLC of sinus gland extracts in L. vannamei, although such fractions were not further identified. We therefore cannot exclude the possibility of cross-reaction between anti-recombinant VIH and other CHHs in L. vannamei.
It is also known that CHH is involved in reaction to stress, and that levels in the hemolymph increase in several decapod species [25, 27, 28, 30] . CHH levels in hemolymph in juvenile H. americanus fluctuated and peaked 20 days after bilateral eyestalk ablation [27] . We measured a maximum level of VIH of 3.57 pmol ml À1 20 days after bilateral ablation in subadults. It is possible that eyestalk ablation imposes a high level of stress upon animals and is more severe in subadults than in adults. Although these levels are higher than what we expected, we suggest it is reasonable if levels are increased because of stress. This has been observed in other species: CHH levels in the hemolymph of Palaemon elegans were increased from 1.13 6 0.28 pmol ml À1 to 7.12 6 1.81 pmol ml À1 after 30 min after the injection of lipopolysaccharide (2 mg g À1 ) [30] . Moreover, we previously reported in L. vannamei, focusing on the role of VIH as a stress-responsive hormone, that air-exposure and lowsalinity stress increased levels in the hemolymph in subadult males [31] . Our results also suggest that new stress-free methods for inducing ovarian maturation in commercial aquaculture operations are desirable as an alternative to eyestalk ablation.
On the other hand, CHH levels in the hemolymph were increased by the injection of serotonin (5-HT) in bilaterally ablated F. indicus [26] . Levels of 5-HT and dopamine changed in relation to ovarian maturation in L. vannamei, and 5-HT levels increased in the brain, thoracic ganglia, and ovary with advancing maturity [12] . These previous reports suggest that 5-HT levels were synchronized with VG levels in L. vannamei. However, 5-HT increased the levels of CHH in hemolymph in a manner similar to stress response in F. indicus [26] and P. elegans [32] . Although we did not measure 5-HT, it may induce increased levels of CHH in the hemolymph with the advance of ovarian maturation.
As noted above, we previously examined whether VIH in L. vannamei could act as CHH [31] . VIH is classified as a type II CHH-family peptide, but the six other peptides that we previously purified from the sinus gland and that could inhibit VG mRNA were type I peptides. CHH-family peptides are structurally similar, and therefore likely to have similar functioning. Some CHHs in H. americanus triggered the onset of vitellogenesis and stimulated oocyte maturation [18] . Therefore, VIH in the hemolymph of L. vannamei may have an alternative role during late vitellogenesis, although it inhibits vitellogenesis at the immature and previtellogenic stages.
In this study, we revealed the dynamics of change in the levels of VG and VIH in relation to molting and ovarian maturation induced by eyestalk ablation, but questions remain, such as how VIH is switched to alternative functions and how it acts in concert with neurotransmitters and other CHH-family peptides to control ovarian maturation. Further research on the functioning of VIH, CHH, and 5-HT in relation to ovarian maturation is required in order to fully reveal the physiological mechanisms of reproduction.
